Ramsay Générale de Santé SA (EPA:GDS)
France · Delayed Price · Currency is EUR 8.66
-0.04 (-0.46%)
Nov 12, 2026, 10:00 AM CET
Ramsay Générale de Santé Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 5,381 | 5,208 | 5,007 | 4,702 | 4,301 | |
Revenue Growth | 3.33% | 4.02% | 6.49% | 9.31% | 6.92% |
Cost of Revenue | 3,886 | 3,780 | 3,635 | 3,478 | 3,135 |
Gross Profit | 1,495 | 1,428 | 1,372 | 1,224 | 1,166 |
Selling, General & Admin | 81.4 | 85.7 | 80.3 | 86.2 | 84.6 |
Other Operating Expenses | 774.1 | 719.2 | 678.9 | 492.4 | 333.4 |
Operating Expenses | 1,296 | 1,239 | 1,186 | 981.8 | 795.3 |
Operating Income | 198.8 | 189.1 | 185.9 | 242.1 | 370.9 |
Interest Expense | -194.4 | -199.1 | -177 | -156.4 | -124.1 |
Interest & Investment Income | 4.1 | 6.3 | 3.3 | 10.4 | 1.2 |
Earnings From Equity Investments | - | - | - | - | -0.1 |
Other Non Operating Income (Expenses) | -4.9 | -15.5 | -29.4 | -6.7 | 16.8 |
EBT Excluding Unusual Items | 3.6 | -19.2 | -17.2 | 89.4 | 264.7 |
Merger & Restructuring Charges | -18 | -9.2 | -12.8 | -12.6 | 3.5 |
Gain (Loss) on Sale of Assets | - | - | - | 35.5 | 7.5 |
Asset Writedown | -4.2 | -2.2 | -23.3 | - | -0.8 |
Other Unusual Items | 11.6 | -2.8 | 12.5 | -24.6 | -89.8 |
Pretax Income | -7 | -33.4 | -40.8 | 87.7 | 185.1 |
Income Tax Expense | 19.5 | 1.6 | -4.1 | 23.8 | 57.3 |
Earnings From Continuing Operations | -26.5 | -35 | -36.7 | 63.9 | 127.8 |
Earnings From Discontinued Operations | -6.8 | -3.1 | - | - | - |
Net Income to Company | -33.3 | -38.1 | -36.7 | 63.9 | 127.8 |
Minority Interest in Earnings | -15 | -16 | -17.2 | -14.5 | -9.4 |
Net Income | -48.3 | -54.1 | -53.9 | 49.4 | 118.4 |
Net Income to Common | -48.3 | -54.1 | -53.9 | 49.4 | 118.4 |
Net Income Growth | - | - | - | -58.28% | 82.15% |
Shares Outstanding (Basic) | 110 | 110 | 110 | 110 | 110 |
Shares Outstanding (Diluted) | 110 | 110 | 110 | 110 | 110 |
Shares Change | -0.00% | 0.00% | 0.00% | -0.01% | 0.01% |
EPS (Basic) | -0.44 | -0.49 | -0.49 | 0.45 | 1.07 |
EPS (Diluted) | -0.44 | -0.49 | -0.49 | 0.45 | 1.07 |
EPS Growth | - | - | - | -58.17% | 81.68% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 380.8 | 550.9 | 418.3 | 426.7 | 68.9 |
Free Cash Flow Per Share | 3.45 | 4.99 | 3.79 | 3.87 | 0.62 |
Gross Margin | 27.78% | 27.42% | 27.40% | 26.03% | 27.12% |
Operating Margin | 3.69% | 3.63% | 3.71% | 5.15% | 8.62% |
Profit Margin | -0.90% | -1.04% | -1.08% | 1.05% | 2.75% |
Free Cash Flow Margin | 7.08% | 10.58% | 8.36% | 9.08% | 1.60% |
EBITDA | 361.4 | 362.7 | 366.6 | 414.3 | 533.3 |
EBITDA Margin | 6.72% | 6.96% | 7.32% | 8.81% | 12.40% |
D&A For EBITDA | 162.6 | 173.6 | 180.7 | 172.2 | 162.4 |
EBIT | 198.8 | 189.1 | 185.9 | 242.1 | 370.9 |
EBIT Margin | 3.69% | 3.63% | 3.71% | 5.15% | 8.62% |
Effective Tax Rate | - | - | - | 27.14% | 30.96% |